Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_assertion type Assertion NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_head.
- NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_assertion description "[These data suggest the possible advantages of strategies of type I IFN gene transfer (with respect to the use of the exogenous cytokine) for the treatment of patients with some HHV-8-induced malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_provenance.
- NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_assertion evidence source_evidence_literature NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_provenance.
- NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_assertion SIO_000772 10574624 NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_provenance.
- NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_assertion wasDerivedFrom befree-20140225 NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_provenance.
- NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_assertion wasGeneratedBy ECO_0000203 NP254096.RANE2Cw-fSecAzz0bu2W645_RQYHFdBnkRZJpQN3kjyAc130_provenance.